2SLGBTQIA+ Patient & Public Advisory Team for Equity, Diversity & Inclusion in Organ Donation and Transplantation in Canada

Study Lead

Dr. Murdoch Leeies

University of Manitoba


Dr. Murdoch Leeies‘ team at University of Manitoba is forming a 2SLGBTQIA+ patient/family advisory team and is looking for interested people who have been involved with the organ donation or transplantation system. If you are a 2SLGBTQIA+ identifying person who has been a living organ donor, a solid organ transplant recipient or the substitute-decision maker or caregiver of a 2SLGBTQIA+ person who was considered for donation after death (whether they did or did not donate) then they hope you will consider registering your interest to participate.

The team hopes that your engagement will help them to design research as well as policies that can improve equity for 2SLGBTQIA+ people in our health system. We greatly value your participation.

Type of Participation

Patient Partnership




All provinces and territories

Related studies

  • Take part in one hemodialysis session to evaluate Qidni Labs’ nearly waterless and portable dialysis system

    Overview: Qidni Labs is inviting up to 30 patients with kidney failure to take part in research studying the “Qidni/D”, an investigational hemodialysis device, as a possible treatment for kidney failure.

    Study type: Clinical Trial

    May 16, 2023

  • Person-centered integrated care delivery for patients with chronic kidney disease and multimorbidity in the primary care setting and primary-nephrology care interface

    Overview: Participants are invited to complete a 15-minute survey with questions about their experience with kidney care in Alberta.

    Study type: Survey

    May 16, 2023

  • Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE)

    Overview: The purpose of this study is to determine if spironolactone reduces death or hospitalization for heart failure and is well tolerated in patients that require dialysis.

    Study type: Clinical Trial

    April 28, 2023